31 Oct, EOD - Indian

SENSEX 79389.06 (-0.69)

Nifty 50 24205.35 (-0.56)

Nifty Bank 51475.35 (-0.64)

Nifty IT 40407.55 (-3.03)

Nifty Midcap 100 56112.85 (-0.40)

Nifty Next 50 69911.75 (-0.51)

Nifty Pharma 22735.55 (1.61)

Nifty Smallcap 100 18602.6 (1.15)

31 Oct, EOD - Global

NIKKEI 225 38162.69 (-2.35)

HANG SENG 20635.73 (1.57)

S&P 5761.25 (0.19)

Login/Signup

You are Here : Home > Research

23-Oct-2024

Dr Lal Pathlabs

NP increased 18.21%

'On consolidated basis

Quarter ended September 2024 compared with Quarter ended September 2023.

Net sales (including other operating income) of Dr Lal Pathlabs has increased 9.80% to Rs 660.2 crore.  Operating profit margin has jumped from 29.57% to 30.67%, leading to 13.89% rise in operating profit to Rs 202.50 crore.  Raw material cost as a % of total sales (net of stock adjustments) decreased from 20.36% to 19.28%.   Employee cost increased from 17.53% to 18.78%.   Other expenses fell from 32.55% to 31.26%.   Selling and administration expenses rose from 14.17% to 14.19%.   

Other income rose 20.99% to Rs 21.9 crore.  PBIDT rose 14.55% to Rs 224.4 crore.  Provision for interest fell 23.08% to Rs 6 crore.  Loan funds declined from Rs 299.20 crore as of 30 September 2023 to Rs 198.50 crore as of 30 September 2024.  Inventories rose to Rs 46.80 crore as o...



Pleaselogin & subscribe to view the full report.

More Reports
More Reports View Company Information